首页 > 最新文献

Journal of the Turkish German Gynecological Association最新文献

英文 中文
Obstetric brachial plexus injury: risk factors and clinical follow-up results. 产科臂丛神经损伤:危险因素及临床随访结果。
IF 1.4 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-09-03 Epub Date: 2025-08-22 DOI: 10.4274/jtgga.galenos.2025.2025-3-3
Oğuz Arslan, Burak Giray, Niyazi Tuğ

Objective: Obstetric brachial plexus injury is a significant cause of neonatal morbidity. The aim of this study was to evaluate the maternal and perinatal factors associated with plexus injury and to analyze clinical follow-up outcomes and parental caregiving burden.

Material and methods: This study was conducted as a retrospective descriptive study at the maternity center of a tertiary hospital. Deliveries resulting in obstetric plexus injury between February 2018 and December 2023 were included in the study. Out of 27,695 live births, 28 infants with plexus injury were identified and analyzed.

Results: Of the women who gave birth to infants with brachial plexus injury, 25 (89.3%) were aged 21-34 years, and 22 (78.6%) had a body mass index between 25 and 29.99 kg/m2. Of the cohort, 16 (57.1%) were multiparous, and 3 (10.7%) had gestational diabetes. In addition, 15 (53.6%) women underwent labor induction, and all had vaginal deliveries. Shoulder dystocia occurred in 11 deliveries (39.3%). Of the newborns with brachial plexus injury, 25 (89.3%) had Erb's palsy. The mean follow-up period for the infants was 12 (3-31) months. Injury recovery occurred in 24 babies (85.7%), while four babies (14.3%) experienced permanent injury. Regarding parental caregiving burden, 22 parents (78.6%) reported "no to mild burden," while six parents (21.4%) reported a "mild to moderate burden." No parents reported "moderate to severe" or "severe burden". All newborns with permanent damage developed shoulder dystocia at delivery (p=0.007).

Conclusion: Most infants with plexus injury recovered, while permanent injury was linked to shoulder dystocia, and parental caregiving burden was generally low.

目的:产科臂丛损伤是新生儿发病的重要原因。本研究的目的是评估与臂丛损伤相关的母体和围产期因素,并分析临床随访结果和父母照顾负担。材料与方法:本研究在某三级医院产科中心进行回顾性描述性研究。该研究包括2018年2月至2023年12月期间导致产科神经丛损伤的分娩。在27,695名活产婴儿中,有28名婴儿被确定并分析了臂丛损伤。结果:生下臂丛神经损伤婴儿的产妇中,年龄在21 ~ 34岁的有25例(89.3%),体质指数在25 ~ 29.99 kg/m2之间的有22例(78.6%)。在队列中,16例(57.1%)为多胎,3例(10.7%)患有妊娠糖尿病。此外,15名(53.6%)妇女进行了引产,并且都是阴道分娩。11例(39.3%)发生肩难产。臂丛神经损伤新生儿中有Erb麻痹25例(89.3%)。平均随访时间为12(3-31)个月。损伤恢复24例(85.7%),永久性损伤4例(14.3%)。对于父母的照顾负担,22名家长(78.6%)回答“没有到轻度负担”,6名家长(21.4%)回答“轻度到中度负担”。没有家长报告“中度至重度”或“严重负担”。所有永久性损伤的新生儿在分娩时均出现肩难产(p=0.007)。结论:臂丛神经损伤患儿多数能恢复,而永久性损伤多与肩难产有关,父母照顾负担普遍较轻。
{"title":"Obstetric brachial plexus injury: risk factors and clinical follow-up results.","authors":"Oğuz Arslan, Burak Giray, Niyazi Tuğ","doi":"10.4274/jtgga.galenos.2025.2025-3-3","DOIUrl":"10.4274/jtgga.galenos.2025.2025-3-3","url":null,"abstract":"<p><strong>Objective: </strong>Obstetric brachial plexus injury is a significant cause of neonatal morbidity. The aim of this study was to evaluate the maternal and perinatal factors associated with plexus injury and to analyze clinical follow-up outcomes and parental caregiving burden.</p><p><strong>Material and methods: </strong>This study was conducted as a retrospective descriptive study at the maternity center of a tertiary hospital. Deliveries resulting in obstetric plexus injury between February 2018 and December 2023 were included in the study. Out of 27,695 live births, 28 infants with plexus injury were identified and analyzed.</p><p><strong>Results: </strong>Of the women who gave birth to infants with brachial plexus injury, 25 (89.3%) were aged 21-34 years, and 22 (78.6%) had a body mass index between 25 and 29.99 kg/m2. Of the cohort, 16 (57.1%) were multiparous, and 3 (10.7%) had gestational diabetes. In addition, 15 (53.6%) women underwent labor induction, and all had vaginal deliveries. Shoulder dystocia occurred in 11 deliveries (39.3%). Of the newborns with brachial plexus injury, 25 (89.3%) had Erb's palsy. The mean follow-up period for the infants was 12 (3-31) months. Injury recovery occurred in 24 babies (85.7%), while four babies (14.3%) experienced permanent injury. Regarding parental caregiving burden, 22 parents (78.6%) reported \"no to mild burden,\" while six parents (21.4%) reported a \"mild to moderate burden.\" No parents reported \"moderate to severe\" or \"severe burden\". All newborns with permanent damage developed shoulder dystocia at delivery (p=0.007).</p><p><strong>Conclusion: </strong>Most infants with plexus injury recovered, while permanent injury was linked to shoulder dystocia, and parental caregiving burden was generally low.</p>","PeriodicalId":17440,"journal":{"name":"Journal of the Turkish German Gynecological Association","volume":"26 3","pages":"204-211"},"PeriodicalIF":1.4,"publicationDate":"2025-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12406965/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144958980","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Twin pregnancy: adolescents versus adults. 双胎妊娠:青少年与成人。
IF 1.4 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-09-03 DOI: 10.4274/jtgga.galenos.2025.2025-5-11
Shaymaa Kadhim Jasim, Rusul Daad, Abbas Oweid Olewi, Hayder Al-Momen, Rand Almomen

Objective: Various nations, and this could create a new era of very young mothers which apply an additional pressure on obstetrical and neonatal health system. In cases of twin pregnancy, the burden would be maximized. The aim was to highlight the differences of obstetrical and neonatal outcomes of twin adolescent pregnancy compared to adults.

Material and methods: Data were collected prospectively over five years from a tertiary obstetric and neonatal center. Two categories of twin pregnancies were formed from adolescents as the case group and adults as controls.

Results: The adolescent group included 59 women and adults numbered 782. The adolescents had significantly higher rates of very preterm delivery, defined as gestational age [(GA) 28≤32 weeks] [odds ratio (95% confidence interval) 2.64 (1.26-3.92)], p<0.05], and significantly lower mean GA than adults (36.6±4.1 versus 37.8±2.6, weeks respectively). Babies delivered to adolescents had significantly lower mean birth weight (1936.5±0.604 g), birth height (43.4±4.3 cm), and occipitofrontal circumference (OFC) (30.8±3.3 cm). Moreover, there was a significantly higher frequency of neonates with APGAR score <7 at the fifth minute [31 (52.54)], low birth weight [53 (89.83)], and neonatal intensive care unit (NICU) admission [38 (64.41)].

Conclusion: Twin adolescent pregnancy had significantly elevated metrics for obstetric and neonatal complications, which were especially notable for very preterm delivery, low neonatal birth weight and short birth length, and reduced OFC, APGAR score <7 at the fifth minute, and NICU admission rate.

目的:不同的国家,这可能会创造一个非常年轻的母亲的新时代,这对产科和新生儿卫生系统施加额外的压力。在双胎妊娠的情况下,负担将会最大化。目的是强调与成人相比,双胎青少年怀孕的产科和新生儿结局的差异。材料和方法:从一家三级产科和新生儿中心前瞻性地收集了5年以上的数据。双胎妊娠分为两类,青少年为病例组,成人为对照组。结果:青少年组女性59人,成人782人。结论:青少年双胎妊娠显著增加了严重早产的发生率,定义为胎龄[(GA) 28≤32周][优势比(95%置信区间)2.64(1.26-3.92)]。结论:青少年双胎妊娠显著增加了产科和新生儿并发症的指标,尤其是严重早产、新生儿体重低和出生体长短,并降低了OFC、APGAR评分
{"title":"Twin pregnancy: adolescents versus adults.","authors":"Shaymaa Kadhim Jasim, Rusul Daad, Abbas Oweid Olewi, Hayder Al-Momen, Rand Almomen","doi":"10.4274/jtgga.galenos.2025.2025-5-11","DOIUrl":"10.4274/jtgga.galenos.2025.2025-5-11","url":null,"abstract":"<p><strong>Objective: </strong>Various nations, and this could create a new era of very young mothers which apply an additional pressure on obstetrical and neonatal health system. In cases of twin pregnancy, the burden would be maximized. The aim was to highlight the differences of obstetrical and neonatal outcomes of twin adolescent pregnancy compared to adults.</p><p><strong>Material and methods: </strong>Data were collected prospectively over five years from a tertiary obstetric and neonatal center. Two categories of twin pregnancies were formed from adolescents as the case group and adults as controls.</p><p><strong>Results: </strong>The adolescent group included 59 women and adults numbered 782. The adolescents had significantly higher rates of very preterm delivery, defined as gestational age [(GA) 28≤32 weeks] [odds ratio (95% confidence interval) 2.64 (1.26-3.92)], p<0.05], and significantly lower mean GA than adults (36.6±4.1 versus 37.8±2.6, weeks respectively). Babies delivered to adolescents had significantly lower mean birth weight (1936.5±0.604 g), birth height (43.4±4.3 cm), and occipitofrontal circumference (OFC) (30.8±3.3 cm). Moreover, there was a significantly higher frequency of neonates with APGAR score <7 at the fifth minute [31 (52.54)], low birth weight [53 (89.83)], and neonatal intensive care unit (NICU) admission [38 (64.41)].</p><p><strong>Conclusion: </strong>Twin adolescent pregnancy had significantly elevated metrics for obstetric and neonatal complications, which were especially notable for very preterm delivery, low neonatal birth weight and short birth length, and reduced OFC, APGAR score <7 at the fifth minute, and NICU admission rate.</p>","PeriodicalId":17440,"journal":{"name":"Journal of the Turkish German Gynecological Association","volume":"26 3","pages":"174-179"},"PeriodicalIF":1.4,"publicationDate":"2025-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12406967/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144958446","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The future of research on vulvar intraepithelial neoplasia: towards precision diagnostics and risk stratification. 外阴上皮内瘤变研究的未来:走向精确诊断和风险分层。
IF 1.4 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-09-03 Epub Date: 2025-07-29 DOI: 10.4274/jtgga.galenos.2025.2025-7-5
Mario Preti, Niccolò Gallio, Jacob Bornstein, Elmar Joura, Koray Görkem Saçıntı, Pedro Vieira Baptista

Vulvar intraepithelial neoplasia (VIN) represents a heterogeneous group of premalignant lesions arising through distinct human papillomavirus (HPV)-associated and HPV-independent pathways. Despite well-characterized differences in etiology, prognosis, and progression risk, current management remains largely uniform and predominantly surgical. This one-size-fits-all approach neglects opportunities for individualized care and exposes patients, particularly younger women and those with multifocal disease, to potentially avoidable psychosexual morbidity. Recent advances in molecular pathology, including immunohistochemistry, genomic profiling, DNA methylation analysis, and copy number alteration detection, offer promising avenues for refining diagnostic precision and enabling risk stratification. Integration of markers such as p16INK4a, p53, and emerging methylation panels into diagnostic workflows may improve differentiation between lesion subtypes, guide surveillance, and identify candidates for conservative therapy. Moreover, the unique pathogenesis of vulvar high-grade squamous intraepithelial neoplasia, which diverges from squamocolumnar junction (SCJ)-driven models seen in other HPV-associated cancers, highlights the need for focused research on host-virus interactions and early oncogenic events in non-SCJ epithelium. Future directions include non-invasive sampling methods, molecularly-guided surveillance protocols, therapeutic HPV vaccines, and combined immunomodulatory treatments to reduce the burden of excisional therapy. Establishing precision-based approaches for VIN could not only preserve vulvar integrity and function but also improve oncological outcomes through targeted prevention and early intervention strategies.

外阴上皮内瘤变(VIN)代表了一组异质性的癌前病变,通过不同的人乳头瘤病毒(HPV)相关和不依赖HPV的途径引起。尽管病因、预后和进展风险有明显的差异,但目前的治疗方法仍然基本一致,主要是手术治疗。这种一刀切的方法忽视了个性化护理的机会,并使患者,特别是年轻妇女和患有多灶性疾病的患者,面临本可避免的性心理疾病。分子病理学的最新进展,包括免疫组织化学、基因组图谱、DNA甲基化分析和拷贝数改变检测,为提高诊断精度和实现风险分层提供了有希望的途径。将p16INK4a、p53和新出现的甲基化小组等标记物整合到诊断工作流程中,可以改善病变亚型之间的区分,指导监测,并确定保守治疗的候选者。此外,外阴高级别鳞状上皮内瘤变的独特发病机制不同于其他hpv相关癌症中鳞状柱结(SCJ)驱动的模型,这突出了对非SCJ上皮中宿主-病毒相互作用和早期致癌事件的重点研究的必要性。未来的方向包括非侵入性采样方法,分子引导的监测方案,治疗性HPV疫苗,以及联合免疫调节治疗,以减少切除治疗的负担。建立基于精准度的VIN方法,不仅可以保护外阴的完整性和功能,还可以通过有针对性的预防和早期干预策略改善肿瘤预后。
{"title":"The future of research on vulvar intraepithelial neoplasia: towards precision diagnostics and risk stratification.","authors":"Mario Preti, Niccolò Gallio, Jacob Bornstein, Elmar Joura, Koray Görkem Saçıntı, Pedro Vieira Baptista","doi":"10.4274/jtgga.galenos.2025.2025-7-5","DOIUrl":"10.4274/jtgga.galenos.2025.2025-7-5","url":null,"abstract":"<p><p>Vulvar intraepithelial neoplasia (VIN) represents a heterogeneous group of premalignant lesions arising through distinct human papillomavirus (HPV)-associated and HPV-independent pathways. Despite well-characterized differences in etiology, prognosis, and progression risk, current management remains largely uniform and predominantly surgical. This one-size-fits-all approach neglects opportunities for individualized care and exposes patients, particularly younger women and those with multifocal disease, to potentially avoidable psychosexual morbidity. Recent advances in molecular pathology, including immunohistochemistry, genomic profiling, DNA methylation analysis, and copy number alteration detection, offer promising avenues for refining diagnostic precision and enabling risk stratification. Integration of markers such as p16INK4a, p53, and emerging methylation panels into diagnostic workflows may improve differentiation between lesion subtypes, guide surveillance, and identify candidates for conservative therapy. Moreover, the unique pathogenesis of vulvar high-grade squamous intraepithelial neoplasia, which diverges from squamocolumnar junction (SCJ)-driven models seen in other HPV-associated cancers, highlights the need for focused research on host-virus interactions and early oncogenic events in non-SCJ epithelium. Future directions include non-invasive sampling methods, molecularly-guided surveillance protocols, therapeutic HPV vaccines, and combined immunomodulatory treatments to reduce the burden of excisional therapy. Establishing precision-based approaches for VIN could not only preserve vulvar integrity and function but also improve oncological outcomes through targeted prevention and early intervention strategies.</p>","PeriodicalId":17440,"journal":{"name":"Journal of the Turkish German Gynecological Association","volume":" ","pages":"230-234"},"PeriodicalIF":1.4,"publicationDate":"2025-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12406970/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144731984","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
What is your diagnosis? 你的诊断是什么?
IF 1.4 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-09-03 Epub Date: 2025-08-11 DOI: 10.4274/jtgga.galenos.2025.2024-11-3
Kavita Khoiwal, Shalini Bose, Ravi Hari Phulware, Manisha Perka, Jaya Chaturvedi
{"title":"What is your diagnosis?","authors":"Kavita Khoiwal, Shalini Bose, Ravi Hari Phulware, Manisha Perka, Jaya Chaturvedi","doi":"10.4274/jtgga.galenos.2025.2024-11-3","DOIUrl":"10.4274/jtgga.galenos.2025.2024-11-3","url":null,"abstract":"","PeriodicalId":17440,"journal":{"name":"Journal of the Turkish German Gynecological Association","volume":" ","pages":"235-237"},"PeriodicalIF":1.4,"publicationDate":"2025-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12406959/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144816990","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is HRT a trigger for cancer in postmenopausal patients with a history of endometriosis? HRT是绝经后有子宫内膜异位症患者的癌症诱因吗?
IF 1.4 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-09-03 DOI: 10.4274/jtgga.galenos.2025.2024-8-4
Christos Iavazzo, Ioannis D Gkegkes
{"title":"Is HRT a trigger for cancer in postmenopausal patients with a history of endometriosis?","authors":"Christos Iavazzo, Ioannis D Gkegkes","doi":"10.4274/jtgga.galenos.2025.2024-8-4","DOIUrl":"10.4274/jtgga.galenos.2025.2024-8-4","url":null,"abstract":"","PeriodicalId":17440,"journal":{"name":"Journal of the Turkish German Gynecological Association","volume":"26 3","pages":"238-239"},"PeriodicalIF":1.4,"publicationDate":"2025-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12406973/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144958898","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Optimal leading follicle size for final oocyte maturation in POSEIDON group 3 and 4 poor responders undergoing assisted reproductive technology cycles. 在辅助生殖技术周期中,波塞冬第3组和第4组反应不良者最终卵母细胞成熟的最佳前导卵泡大小。
IF 1.4 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-09-03 DOI: 10.4274/jtgga.galenos.2025.2025-7-8
Nilüfer Akgün, Yavuz Emre Şükür, Batuhan Aslan, Necati Berk Kaplan, Onur Alp Acun, Batuhan Özmen, Murat Sönmezer, Bülent Berker, Cem Somer Atabekoğlu, Ruşen Aytaç

Objective: The aim of this retrospective cohort study was to evaluate the relationship between leading follicle size at the time of human chorionic gonadotropin (hCG) trigger and live birth rates in Patient-Oriented Strategies Encompassing Individualised Oocyte Number (POSEIDON) groups 3 and 4 undergoing assisted reproductive technology cycles using a gonadotropin releasing hormone (GnRH) antagonist protocol. The objective was to identify the optimal leading follicle size for maximizing live birth outcomes in this challenging patient population.

Material and methods: This retrospective cohort study included POSEIDON groups 3 and 4 poor responders aged 20-42 years undergoing intracytoplasmic sperm injection with GnRH antagonist protocol between January 2015 and July 2021. Patients were categorized based on the occurrence of premature ovulation. The primary outcome measures were number of oocytes retrieved, number of metaphase II (MII) oocytes, MII oocyte ratio and follicle oocyte index (FOI). These outcomes were compared across different leading follicle size categories at the time of hCG trigger.

Results: Among the 294 subjects included, 47 (16.2%) had premature ovulation between the trigger and oocyte pick-up days. The mean size of the leading follicle on the day of trigger was significantly higher in the premature ovulation group (19.8±2.4 mm vs.18.7±2 mm, respectively; p<0.001). Multivariate logistic regression analyses identified baseline luteinizing hormone [odds ratio (OR) 1.144, 95% confidence interval (CI) 1.052-1.243; p=0.002], number of follicles >11 mm on the day of trigger (OR 0.580, 95% CI 0.438-0.767; p<0.001), and leading follicle size (OR 1.361, 95% CI 1.130-1.641; p=0.001) as independent predictors of premature ovulation. The FOI and MII/antral follicle count ratios peaked when the leading follicle size was between 16-17 mm.

Conclusion: Individualized triggering based on leading follicle size may provide optimal oocyte retrieval after ovarian stimulation in POSEIDON expected poor responders. While a late trigger may result in premature ovulation, an early trigger may also result in less MII. Triggering when the leading follicle size is between 16.5 and 17 mm may help to prevent these negative outcomes and achieve optimal cycle outcome.

目的:本回顾性队列研究的目的是评估在以患者为导向的包括个体化卵母细胞数量(POSEIDON)的策略中,在使用促性腺激素释放激素(GnRH)拮抗剂方案进行辅助生殖技术周期的第3组和第4组中,人绒毛膜促性腺激素(hCG)触发时先导卵泡大小与活产率之间的关系。目的是确定在这个具有挑战性的患者群体中最大限度地提高活产结果的最佳先导卵泡大小。材料和方法:该回顾性队列研究纳入了POSEIDON 3组和4组,年龄20-42岁,在2015年1月至2021年7月期间接受GnRH拮抗剂方案的胞浆内单精子注射。根据早泄的发生情况对患者进行分类。主要观察指标为回收卵母细胞数、中期II期(MII)卵母细胞数、中期II期卵母细胞比率和卵泡卵母细胞指数(FOI)。在hCG触发时,这些结果在不同主要卵泡大小类别中进行了比较。结果:294例受试者中,47例(16.2%)在触发日和取卵日之间发生早排卵。早排卵组触发当天先导卵泡的平均大小显著高于对照组(分别为19.8±2.4 mm和18.7±2 mm);触发当天先导卵泡的平均大小为11 mm (OR 0.580, 95% CI 0.438-0.767)。结论:基于先导卵泡大小的个体化触发可能为波塞冬预期不良应答者提供卵巢刺激后最佳的卵母细胞回收。虽然晚触发可能导致早泄,但早触发也可能导致MII减少。当主要卵泡大小在16.5和17毫米之间时触发可能有助于防止这些负面结果并实现最佳周期结果。
{"title":"Optimal leading follicle size for final oocyte maturation in POSEIDON group 3 and 4 poor responders undergoing assisted reproductive technology cycles.","authors":"Nilüfer Akgün, Yavuz Emre Şükür, Batuhan Aslan, Necati Berk Kaplan, Onur Alp Acun, Batuhan Özmen, Murat Sönmezer, Bülent Berker, Cem Somer Atabekoğlu, Ruşen Aytaç","doi":"10.4274/jtgga.galenos.2025.2025-7-8","DOIUrl":"10.4274/jtgga.galenos.2025.2025-7-8","url":null,"abstract":"<p><strong>Objective: </strong>The aim of this retrospective cohort study was to evaluate the relationship between leading follicle size at the time of human chorionic gonadotropin (hCG) trigger and live birth rates in Patient-Oriented Strategies Encompassing Individualised Oocyte Number (POSEIDON) groups 3 and 4 undergoing assisted reproductive technology cycles using a gonadotropin releasing hormone (GnRH) antagonist protocol. The objective was to identify the optimal leading follicle size for maximizing live birth outcomes in this challenging patient population.</p><p><strong>Material and methods: </strong>This retrospective cohort study included POSEIDON groups 3 and 4 poor responders aged 20-42 years undergoing intracytoplasmic sperm injection with GnRH antagonist protocol between January 2015 and July 2021. Patients were categorized based on the occurrence of premature ovulation. The primary outcome measures were number of oocytes retrieved, number of metaphase II (MII) oocytes, MII oocyte ratio and follicle oocyte index (FOI). These outcomes were compared across different leading follicle size categories at the time of hCG trigger.</p><p><strong>Results: </strong>Among the 294 subjects included, 47 (16.2%) had premature ovulation between the trigger and oocyte pick-up days. The mean size of the leading follicle on the day of trigger was significantly higher in the premature ovulation group (19.8±2.4 mm vs.18.7±2 mm, respectively; p<0.001). Multivariate logistic regression analyses identified baseline luteinizing hormone [odds ratio (OR) 1.144, 95% confidence interval (CI) 1.052-1.243; p=0.002], number of follicles >11 mm on the day of trigger (OR 0.580, 95% CI 0.438-0.767; p<0.001), and leading follicle size (OR 1.361, 95% CI 1.130-1.641; p=0.001) as independent predictors of premature ovulation. The FOI and MII/antral follicle count ratios peaked when the leading follicle size was between 16-17 mm.</p><p><strong>Conclusion: </strong>Individualized triggering based on leading follicle size may provide optimal oocyte retrieval after ovarian stimulation in POSEIDON expected poor responders. While a late trigger may result in premature ovulation, an early trigger may also result in less MII. Triggering when the leading follicle size is between 16.5 and 17 mm may help to prevent these negative outcomes and achieve optimal cycle outcome.</p>","PeriodicalId":17440,"journal":{"name":"Journal of the Turkish German Gynecological Association","volume":"26 3","pages":"195-203"},"PeriodicalIF":1.4,"publicationDate":"2025-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12406972/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144958928","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of laparoscopic and laparotomic Burch colposuspension in the treatment of stress urinary incontinence. 腹腔镜与开腹Burch悬吊治疗应激性尿失禁的比较。
IF 1.4 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-09-03 Epub Date: 2025-08-18 DOI: 10.4274/jtgga.galenos.2025.2025-4-7
Bilgin Öztürk, Ufuk Atlıhan, Mehmet Emre Peker, Mehmet Uğur Mungan

Objective: To evaluate patients who underwent Burch colposuspension due to stress-type urinary incontinence (SUI) in terms of laparoscopic (L/S) and laparotomy (L/T) approaches.

Material and methods: Women aged 40-70 years who were admitted to our hospital with symptoms of SUI between 2017 and 2024, who underwent surgical treatment for SUI, and who met the inclusion criteria were included. The women were divided into two groups, those who received L/T and those who underwent L/S Burch colposuspension. To assess the impact of SUI on quality of life, several quality-of-life questionnaires, including the urinary distress inventory (UDI-6), the incontinence impact questionnaire (IIQ-7), the short-form-36 (SF-36) physical component summary, and the mental component summary (MCS), were evaluated. Post-operative pain was assessed with a Visual Analog Scale (VAS).

Results: The cohort consisted of 74 patients. The surgical time and estimated blood loss in the L/S group was significantly lower than in the L/T group (both p<0.001). The sixth and 48th-hour VAS score in the L/S group was significantly lower than in the L/T group (both p<0.001). There was a significant decrease in UDI-6 and IIQ-7 score in patients who underwent L/S-Burch colposuspension and L/T-Burch colposuspension at the 6th-month follow-up (p<0.001 and p<0.001, respectively). At the sixth-month follow-up, the SF-36 MCS score was significantly lower in the L/S group compared with the L/T group (p=0.014).

Conclusion: In our study, the results of Burch colposuspension methods were consistent with the literature. L/S-Burch colposuspension is superior in terms of surgical time, blood loss, hospital stay, pain management, and recovery time. The significant decrease in UDI-6 and IIQ-7 scores at the 6-month follow-up shows that both methods provide improvement in urinary incontinence symptoms and increase quality of life.

目的:评价因压力型尿失禁(SUI)而行Burch阴道悬吊的患者在腹腔镜(L/S)和开腹(L/T)两种入路中的应用价值。材料与方法:纳入2017 - 2024年间因SUI接受手术治疗、年龄40-70岁的女性患者,符合入选标准。这些女性被分为两组,一组接受L/T治疗,另一组接受L/S Burch阴道暂停治疗。为了评估SUI对生活质量的影响,我们对尿窘迫量表(UDI-6)、尿失禁影响量表(IIQ-7)、短表36 (SF-36)身体成分总结和精神成分总结(MCS)等生活质量问卷进行了评估。术后疼痛采用视觉模拟评分(VAS)进行评估。结果:该队列包括74例患者。L/S组的手术时间和预估失血量均显著低于L/T组(L/S组的pth VAS评分均显著低于L/T组)(均为pth月随访)。结论:在我们的研究中,Burch阴道悬吊方法的结果与文献一致。L/S-Burch阴道悬吊术在手术时间、出血量、住院时间、疼痛管理和恢复时间方面具有优势。在6个月的随访中,UDI-6和IIQ-7评分显著下降,表明两种方法都能改善尿失禁症状,提高生活质量。
{"title":"Comparison of laparoscopic and laparotomic Burch colposuspension in the treatment of stress urinary incontinence.","authors":"Bilgin Öztürk, Ufuk Atlıhan, Mehmet Emre Peker, Mehmet Uğur Mungan","doi":"10.4274/jtgga.galenos.2025.2025-4-7","DOIUrl":"10.4274/jtgga.galenos.2025.2025-4-7","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate patients who underwent Burch colposuspension due to stress-type urinary incontinence (SUI) in terms of laparoscopic (L/S) and laparotomy (L/T) approaches.</p><p><strong>Material and methods: </strong>Women aged 40-70 years who were admitted to our hospital with symptoms of SUI between 2017 and 2024, who underwent surgical treatment for SUI, and who met the inclusion criteria were included. The women were divided into two groups, those who received L/T and those who underwent L/S Burch colposuspension. To assess the impact of SUI on quality of life, several quality-of-life questionnaires, including the urinary distress inventory (UDI-6), the incontinence impact questionnaire (IIQ-7), the short-form-36 (SF-36) physical component summary, and the mental component summary (MCS), were evaluated. Post-operative pain was assessed with a Visual Analog Scale (VAS).</p><p><strong>Results: </strong>The cohort consisted of 74 patients. The surgical time and estimated blood loss in the L/S group was significantly lower than in the L/T group (both p<0.001). The sixth and 48<sup>th</sup>-hour VAS score in the L/S group was significantly lower than in the L/T group (both p<0.001). There was a significant decrease in UDI-6 and IIQ-7 score in patients who underwent L/S-Burch colposuspension and L/T-Burch colposuspension at the 6<sup>th</sup>-month follow-up (p<0.001 and p<0.001, respectively). At the sixth-month follow-up, the SF-36 MCS score was significantly lower in the L/S group compared with the L/T group (p=0.014).</p><p><strong>Conclusion: </strong>In our study, the results of Burch colposuspension methods were consistent with the literature. L/S-Burch colposuspension is superior in terms of surgical time, blood loss, hospital stay, pain management, and recovery time. The significant decrease in UDI-6 and IIQ-7 scores at the 6-month follow-up shows that both methods provide improvement in urinary incontinence symptoms and increase quality of life.</p>","PeriodicalId":17440,"journal":{"name":"Journal of the Turkish German Gynecological Association","volume":" ","pages":"190-194"},"PeriodicalIF":1.4,"publicationDate":"2025-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12406969/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144873744","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence of high-grade cervical intraepithelial neoplasia in Mexican women aged under 40 years: a cross-sectional study. 40岁以下墨西哥女性高级别宫颈上皮内瘤变的患病率:一项横断面研究。
IF 1.4 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-09-03 DOI: 10.4274/jtgga.galenos.2025.2025-5-2
Esbeidy Guadalupe Jiménez Pérez, Laura Patricia Limón-Toledo, Lizbeth Gabriela Carranza-Bustos, Alejandro González-Ojeda, Gabino Cervantes-Guevara, Enrique Cervantes-Pérez, Sol Ramírez-Ochoa, Sergio Jiram Vázquez-Sánchez, Samantha Emily González-Muñoz, Kathia Dayana Morfín Meza, Jazmín Montserrat Guzmán-Díaz, Vianney Teresita Hernández-Ramirez, Ana Olivia Cortés-Flores, Andrea Socorro Álvarez-Villaseñor, Carlos Enrique Capetillo-Texson, Clotilde Fuentes-Orozco

Objective: Cervical cancer is the second leading cause of cancer mortality among Mexican women aged 20-39 years, driven primarily by persistent human papillomavirus (HPV) infection. To determine the prevalence of high-grade squamous intraepithelial lesions (HSIL) in women under 40 years of age and identify associated risk factors.

Material and methods: An observational, cross-sectional study was conducted, including 359 women under 40 years old who were evaluated at the Gynecology and Obstetrics Medical Unit of Centro Médico Nacional de Occidente. Cervicovaginal cytology results indicative of HSIL were analyzed to determine prevalence and assess correlations with demographic and gynecological factors.

Results: The prevalence of HSIL was 39%, with the highest proportion of cases observed in women aged 35-39 years. The average age of sexual debut was 18.5 years, with an average of 2.93 sexual partners. Women diagnosed with HSIL were more likely to be older, married, and homemakers. HPV infection was highly prevalent across both low-grade squamous intraepithelial lesion and HSIL groups.

Conclusion: A high prevalence of HPV infection was found, mostly in a relatively young population. A significant association between infection and risk factors, like marital status and gynecological/obstetric history, was also demonstrated. The findings also confirmed a relationship between HPV and HSIL.

目的:宫颈癌是墨西哥20-39岁妇女癌症死亡率的第二大原因,主要是由持续的人乳头瘤病毒(HPV)感染引起的。确定40岁以下女性高级别鳞状上皮内病变(HSIL)的患病率,并确定相关的危险因素。材料和方法:进行了一项观察性横断面研究,包括359名40岁以下的妇女,这些妇女在国立西方医学会妇产医学中心接受了评估。对宫颈阴道细胞学结果进行分析,以确定HSIL的患病率,并评估其与人口统计学和妇科因素的相关性。结果:HSIL的患病率为39%,以35 ~ 39岁的女性发病率最高。初次性行为的平均年龄为18.5岁,平均有2.93个性伴侣。被诊断为HSIL的女性更可能是年龄较大、已婚和家庭主妇。HPV感染在低级别鳞状上皮内病变和HSIL组中都非常普遍。结论:HPV感染的流行率较高,主要发生在相对年轻的人群中。感染与危险因素(如婚姻状况和妇科/产科病史)之间存在显著关联。研究结果也证实了HPV和HSIL之间的关系。
{"title":"Prevalence of high-grade cervical intraepithelial neoplasia in Mexican women aged under 40 years: a cross-sectional study.","authors":"Esbeidy Guadalupe Jiménez Pérez, Laura Patricia Limón-Toledo, Lizbeth Gabriela Carranza-Bustos, Alejandro González-Ojeda, Gabino Cervantes-Guevara, Enrique Cervantes-Pérez, Sol Ramírez-Ochoa, Sergio Jiram Vázquez-Sánchez, Samantha Emily González-Muñoz, Kathia Dayana Morfín Meza, Jazmín Montserrat Guzmán-Díaz, Vianney Teresita Hernández-Ramirez, Ana Olivia Cortés-Flores, Andrea Socorro Álvarez-Villaseñor, Carlos Enrique Capetillo-Texson, Clotilde Fuentes-Orozco","doi":"10.4274/jtgga.galenos.2025.2025-5-2","DOIUrl":"10.4274/jtgga.galenos.2025.2025-5-2","url":null,"abstract":"<p><strong>Objective: </strong>Cervical cancer is the second leading cause of cancer mortality among Mexican women aged 20-39 years, driven primarily by persistent human papillomavirus (HPV) infection. To determine the prevalence of high-grade squamous intraepithelial lesions (HSIL) in women under 40 years of age and identify associated risk factors.</p><p><strong>Material and methods: </strong>An observational, cross-sectional study was conducted, including 359 women under 40 years old who were evaluated at the Gynecology and Obstetrics Medical Unit of Centro Médico Nacional de Occidente. Cervicovaginal cytology results indicative of HSIL were analyzed to determine prevalence and assess correlations with demographic and gynecological factors.</p><p><strong>Results: </strong>The prevalence of HSIL was 39%, with the highest proportion of cases observed in women aged 35-39 years. The average age of sexual debut was 18.5 years, with an average of 2.93 sexual partners. Women diagnosed with HSIL were more likely to be older, married, and homemakers. HPV infection was highly prevalent across both low-grade squamous intraepithelial lesion and HSIL groups.</p><p><strong>Conclusion: </strong>A high prevalence of HPV infection was found, mostly in a relatively young population. A significant association between infection and risk factors, like marital status and gynecological/obstetric history, was also demonstrated. The findings also confirmed a relationship between HPV and HSIL.</p>","PeriodicalId":17440,"journal":{"name":"Journal of the Turkish German Gynecological Association","volume":"26 3","pages":"167-173"},"PeriodicalIF":1.4,"publicationDate":"2025-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12406961/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144958420","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Conservative management of idiopathic gross hematuria post-cesarean delivery. 剖宫产后特发性肉眼血尿的保守治疗。
IF 1.4 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-09-03 Epub Date: 2025-07-30 DOI: 10.4274/jtgga.galenos.2025.2025-2-7
Sunayna Lashkari, Arun Kumar Dora, Avantika Gupta, Ketan Mehra
{"title":"Conservative management of idiopathic gross hematuria post-cesarean delivery.","authors":"Sunayna Lashkari, Arun Kumar Dora, Avantika Gupta, Ketan Mehra","doi":"10.4274/jtgga.galenos.2025.2025-2-7","DOIUrl":"10.4274/jtgga.galenos.2025.2025-2-7","url":null,"abstract":"","PeriodicalId":17440,"journal":{"name":"Journal of the Turkish German Gynecological Association","volume":" ","pages":"240-241"},"PeriodicalIF":1.4,"publicationDate":"2025-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12406966/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144742375","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transplacental cancer transmission: a comprehensive review focusing on mechanisms, challenges, and maternal-fetal outcomes. 胎盘癌传播:一项全面的综述,重点是机制、挑战和母胎结局。
IF 1.4 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-09-03 Epub Date: 2025-07-30 DOI: 10.4274/jtgga.galenos.2025.2025-9-8
Mishu Mangla, Seetu Palo, Naina Kumar

The phenomenon of transplacental transmission of cancer, where cancer cells pass from a pregnant mother to her fetus is an extremely rare occurrence. This phenomenon has significant implications for maternal and fetal health, challenging our understanding of cancer biology and maternal-fetal interactions. The literature on transplacental cancer transmission is sparse, consisting mainly of case reports, small cohort studies, and reviews. Examples of cancers that have been transmitted in this way include melanoma, choriocarcinoma, leukaemia, and lymphoma. Understanding this phenomenon is important because it has direct clinical implications for managing pregnant women with cancer and the infant, raises questions about the placental barrier and immune interactions between mother and fetus, and offers insights that could influence cancer biology and treatment strategies. This review aims to evaluate existing data, identify and synthesize evidence on transplacental cancer transmission cases, evaluate cancer types involved, their transmission mechanisms, and clinical outcomes for both mothers and infants. A comprehensive electronic search of databases was conducted for relevant case reports and series, using specific keywords related to vertical and transplacental transmission of cancer. The review elucidates comprehensive information from the reports to understand how cancer transmission occurred and was confirmed as vertical transmission, aiming to enhance knowledge in this critical area of maternal-fetal medicine.

癌症经胎盘传播的现象,即癌细胞从怀孕的母亲传给胎儿,是一种极其罕见的现象。这一现象对母胎健康具有重要意义,挑战了我们对癌症生物学和母胎相互作用的理解。关于胎盘癌传播的文献很少,主要包括病例报告、小队列研究和综述。以这种方式传播的癌症包括黑色素瘤、绒毛膜癌、白血病和淋巴瘤。了解这一现象很重要,因为它对管理患有癌症的孕妇和婴儿具有直接的临床意义,提出了关于胎盘屏障和母亲与胎儿之间免疫相互作用的问题,并提供了可能影响癌症生物学和治疗策略的见解。本综述旨在评估现有数据,识别和综合有关胎盘癌传播病例的证据,评估涉及的癌症类型,其传播机制以及母婴的临床结局。利用与癌症垂直传播和经胎盘传播相关的特定关键词,对相关病例报告和系列进行了全面的数据库电子检索。这篇综述阐述了来自报告的全面信息,以了解癌症传播是如何发生的,并被确认为垂直传播,旨在提高对母胎医学这一关键领域的认识。
{"title":"Transplacental cancer transmission: a comprehensive review focusing on mechanisms, challenges, and maternal-fetal outcomes.","authors":"Mishu Mangla, Seetu Palo, Naina Kumar","doi":"10.4274/jtgga.galenos.2025.2025-9-8","DOIUrl":"10.4274/jtgga.galenos.2025.2025-9-8","url":null,"abstract":"<p><p>The phenomenon of transplacental transmission of cancer, where cancer cells pass from a pregnant mother to her fetus is an extremely rare occurrence. This phenomenon has significant implications for maternal and fetal health, challenging our understanding of cancer biology and maternal-fetal interactions. The literature on transplacental cancer transmission is sparse, consisting mainly of case reports, small cohort studies, and reviews. Examples of cancers that have been transmitted in this way include melanoma, choriocarcinoma, leukaemia, and lymphoma. Understanding this phenomenon is important because it has direct clinical implications for managing pregnant women with cancer and the infant, raises questions about the placental barrier and immune interactions between mother and fetus, and offers insights that could influence cancer biology and treatment strategies. This review aims to evaluate existing data, identify and synthesize evidence on transplacental cancer transmission cases, evaluate cancer types involved, their transmission mechanisms, and clinical outcomes for both mothers and infants. A comprehensive electronic search of databases was conducted for relevant case reports and series, using specific keywords related to vertical and transplacental transmission of cancer. The review elucidates comprehensive information from the reports to understand how cancer transmission occurred and was confirmed as vertical transmission, aiming to enhance knowledge in this critical area of maternal-fetal medicine.</p>","PeriodicalId":17440,"journal":{"name":"Journal of the Turkish German Gynecological Association","volume":" ","pages":"212-229"},"PeriodicalIF":1.4,"publicationDate":"2025-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12406968/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144742341","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of the Turkish German Gynecological Association
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1